
    
      this is a prospective, randomized, controlled study to assess the impact of pentoxifylline
      administration on the modulation of hyporesponsiveness to erythropoietin stimulating agents
      in hemodialysis patients by determining several outcomes from the intervention and control
      groups at the end of the study.These outcomes include;the difference in hemoglobin and
      hematocrit concentration , the difference in inflammatory markers tumor necrosis factor Alpha
      (TNF-α), interleukin-1 Beta (IL-1β),the difference in the dosage of erythropoiesis
      stimulating agents ,and The erythropoietin stimulating agents (ESA) resistance index (ERI).
    
  